Free Trial

Iovance Biotherapeutics (IOVA) Earnings Date, Estimates & Call Transcripts

$9.14
+0.01 (+0.11%)
(As of 09:29 AM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(May. 9)
-$0.42 Beat By $0.03
Consensus EPS
(May. 9)
-$0.45
Skip Charts & View Estimated and Actual Earnings Data

IOVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IOVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Iovance Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.47)($0.38)($0.43)
Q2 20243($0.46)($0.32)($0.39)
Q3 20243($0.46)($0.33)($0.38)
Q4 20243($0.49)($0.24)($0.34)
FY 202412($1.88)($1.27)($1.54)
Q1 20251($0.22)($0.22)($0.22)
Q2 20251($0.22)($0.22)($0.22)
Q3 20251($0.22)($0.22)($0.22)
Q4 20251($0.21)($0.21)($0.21)
FY 20254($0.87)($0.87)($0.87)
Q1 20261($0.17)($0.17)($0.17)
Q2 20261($0.15)($0.15)($0.15)

IOVA Earnings Date and Information

Iovance Biotherapeutics last announced its quarterly earnings data on May 9th, 2024. The biotechnology company reported ($0.42) earnings per share for the quarter, beating the consensus estimate of ($0.45) by $0.03. The company earned $0.72 million during the quarter, compared to analysts' expectations of $1.99 million. Its quarterly revenue was up 71400.0% on a year-over-year basis. Iovance Biotherapeutics has generated ($1.80) earnings per share over the last year (($1.80) diluted earnings per share). Earnings for Iovance Biotherapeutics are expected to grow in the coming year, from ($1.35) to ($0.86) per share. Iovance Biotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Iovance Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
5/9/2024Q1 2024($0.45)($0.42)+$0.03($0.42)$1.99 million$0.72 million    
2/28/2024Q4 2023($0.44)($0.45)($0.01)($0.45)$1.44 million$0.48 million    
11/7/2023Q3 2023($0.46)($0.46)-($0.46)$4.50 million$0.47 million    
8/8/2023Q2 2023($0.81)($0.47)+$0.34($0.47)$3.91 million$0.24 million    
5/9/2023Q1 2023($0.84)($0.50)+$0.34($0.50)--    
2/28/2023Q4 2022($0.64)($0.64)-($0.64)--    
11/3/2022Q3 2022($0.64)($0.63)+$0.01($0.63)--
8/4/2022Q2 2022($0.60)($0.63)($0.03)($0.63)--    
5/5/2022Q1 2022($0.64)($0.58)+$0.06($0.58)-$12.00 million    
2/24/2022Q4 2021($0.56)($0.63)($0.07)($0.63)--    
11/4/2021Q3 2021($0.53)($0.55)($0.02)($0.55)--    
8/5/2021Q2 2021($0.51)($0.53)($0.02)($0.53)--    
5/6/2021Q1 2021($0.48)($0.51)($0.03)($0.51)--  
2/24/2021Q4 2020($0.44)($0.47)($0.03)($0.47)--  
11/5/2020Q3 2020($0.46)($0.40)+$0.06($0.40)--  
8/6/2020Q2 2020($0.52)($0.47)+$0.05($0.47)--  
5/5/2020Q1 2020($0.53)($0.55)($0.02)($0.55)--  
2/25/2020Q4 2019($0.42)($0.50)($0.08)($0.50)--  
11/4/2019Q3 2019($0.39)($0.40)($0.01)($0.40)--  
8/1/2019Q2 2019($0.29)($0.38)($0.09)($0.38)--

Iovance Biotherapeutics Earnings - Frequently Asked Questions

When is Iovance Biotherapeutics's earnings date?

Iovance Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on IOVA's earnings history.

Did Iovance Biotherapeutics beat their earnings estimates last quarter?

In the previous quarter, Iovance Biotherapeutics (NASDAQ:IOVA) reported ($0.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.03. Learn more on analysts' earnings estimate vs. IOVA's actual earnings.

How can I listen to Iovance Biotherapeutics's earnings conference call?

The conference call for Iovance Biotherapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Iovance Biotherapeutics's conference call transcript?

The conference call transcript for Iovance Biotherapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Iovance Biotherapeutics generate each year?

Iovance Biotherapeutics (NASDAQ:IOVA) has a recorded annual revenue of $1.19 million.

How much profit does Iovance Biotherapeutics generate each year?

Iovance Biotherapeutics (NASDAQ:IOVA) has a recorded net income of -$444.04 million. IOVA has generated -$1.80 earnings per share over the last four quarters.

What is Iovance Biotherapeutics's EPS forecast for next year?

Iovance Biotherapeutics's earnings are expected to grow from ($1.35) per share to ($0.86) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:IOVA) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners